Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Geoffrey Schreiber

Dentist, Oral and Maxillofacial Surgery Virginia Beach, VA Doctor of Dentistry

NPI 1689011009 CMS profile 1264571

6033 Providence Rd, Virginia Beach, VA 23464

Open in the dashboard

General payments

$4,161

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Geoffrey Schreiber of Virginia Beach, VA is reported in the CMS Open Payments database as having received $4,161 across 84 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $952 18
2024 General $1,136 21
2023 General $442 12
2022 General $553 9
2021 General $336 7
2020 General $193 5
2019 General $549 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Geoffrey Schreiber
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Geoffrey Schreiber were reported at $952. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Geoffrey Schreiber Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $549 $142 $50–$420 $163
2020 $193 $96 $36–$277 $114
2021 $336 $138 $45–$419 $132
2022 $553 $144 $48–$367 $149
2023 $442 $153 $55–$399 $160
2024 $1,136 $152 $50–$400 $164
2025 $952 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $1,444 31 payments
  2. BioHorizons Implant Systems Inc. $1,229 27 payments
  3. Zimvie Inc. $342 5 payments
  4. Nobel Biocare USA $318 7 payments
  5. Stryker Corporation $306 2 payments
  6. Dentsply Sirona Inc $218 3 payments
  7. DePuy Synthes Sales Inc. $101 1 payment
  8. Tulsa Dental Products LLC $88 2 payments
  9. Kowa Pharmaceuticals America, Inc. $28 2 payments
  10. Zimmer Biomet Holdings, Inc. $27 1 payment
  11. Other $59 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,765 74 payments
  2. Gift $291 6 payments
  3. Entertainment $56 3 payments
  4. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. BIOHORIZONS Implant Dentistry $735 18 payments
  2. BIOHORIZONS Implant Dentistry $735 18 payments
  3. BIOHORIZONS Implant Dentistry $735 18 payments
  4. BIOHORIZONS Implant Dentistry $735 18 payments
  5. BIOHORIZONS Implant Dentistry $735 18 payments
  6. BioHorizons Dental Implants $493 9 payments
  7. ASTRA TECH Implant System $162 2 payments
  8. BioSet $159 2 payments
  9. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $154 1 payment
  10. VSP SYSTEM, VSP CRANIAL $153 1 payment
  11. Other $1,117 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

847

Median for Oral Surgery (Dentist only): 288

Drug cost

$2,027

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

16.2%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 277 $999
Amoxicillin Generic 201 $368
Ibuprofen Generic 156 $247
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 126 $225
Azithromycin Generic 34 $126
Tramadol Hcl Generic 42 $46
Ibu Ibuprofen Brand 11 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$8,476

Medicare's payments for the services billed

Medicare patients

47

Average age 77

Services billed

73

25 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 32%
Ischemic heart disease 28%
Diabetes 26%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record